imatinib mesylate has been researched along with Neoplasm Metastasis, Unknown Primary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, S; Fujiwara, Y; Kamei, R; Kitamura, Y; Matsui, H; Nagano, H; Sakamoto, K; Yamamoto, T; Yoshino, S | 1 |
| Arce-Lara, C; Benson, DM; Clinton, SK; Jimenez, RE; Monk, JP; Patel, VR; Shah, MH | 1 |
| Dova, L; Fountzilas, G; Georgiou, I; Golfinopoulos, V; Malamou-Mitsi, V; Ntemou, A; Pavlidis, N; Pentheroudakis, G; Vartholomatos, G | 1 |
3 other study(ies) available for imatinib mesylate and Neoplasm Metastasis, Unknown Primary
| Article | Year |
|---|---|
[A Case on the Long‒Term Effect of Imatinib on GIST of Unknown Primary Origin with Multiple Liver Metastases, Peritoneal Dissemination, and Bone Metastasis].
Topics: Antineoplastic Agents; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Middle Aged; Neoplasms, Unknown Primary | 2021 |
Gastrointestinal stromal tumors involving the prostate: presentation, course, and therapeutic approach.
Topics: Antineoplastic Agents; Benzamides; Biopsy, Needle; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasms, Unknown Primary; Piperazines; Prostatic Neoplasms; Pyrimidines; Treatment Outcome | 2007 |
Targeting c-KIT, PDGFR in cancer of unknown primary: a screening study for molecular markers of benefit.
Topics: Aged; Aged, 80 and over; Benzamides; Exons; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Indoles; Male; Middle Aged; Mutation; Neoplasms, Unknown Primary; Piperazines; Polymorphism, Genetic; Prognosis; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Receptors, Platelet-Derived Growth Factor; Sunitinib | 2008 |